Vertex Pharmaceuticals Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Consensus Rating of “Moderate Buy” from Analysts
Vertex Pharmaceuticals J2 Capital Management Inc Buys New Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Vertex Pharmaceuticals XtalPi and Eli Lilly Collaboration Revolutionizing Drug Discovery with AI and Robotics
Vertex Pharmaceuticals Vertex Pharmaceuticals Non-GAAP EPS of $3.05 beats by $0.05, revenue of $2.37B beats by $30M (NASDAQ:VRTX)
